FCE News
https://fcenews.it/index.php 2017-03-18T02:10:04Z Joomla! 1.5 - Open Source Content Management
Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor
2017-02-01T08:00:00Z 2017-02-01T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=215775:does-risk-lymphoma-patients&catid=1016:reumatologia&Itemid=138 Annals of the Rheumatic Diseases current issue [email protected]
We read with interest the paper by Mercer et al1 focusing on the risk of lymphoma in patients included in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BS ... ...
We read with interest the paper by Mercer et al1 focusing on the risk of lymphoma in patients included in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BS ... ...
Response to: 'Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor by Nocturne et al
2017-02-01T08:00:00Z 2017-02-01T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=215776:response-does-risk-lymphoma&catid=1016:reumatologia&Itemid=138 Annals of the Rheumatic Diseases current issue [email protected]
We thank Nocturne et al1 for their interest and comments on our recent paper, which looked at lymphoma risk over the medium term in a cohort of patients receiving tumour necrosis factor inhi ... ...
We thank Nocturne et al1 for their interest and comments on our recent paper, which looked at lymphoma risk over the medium term in a cohort of patients receiving tumour necrosis factor inhi ... ...
What is rheumatoid arthritis Considering consequences of changed classification criteria
2017-02-01T08:00:00Z 2017-02-01T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=215777:what-rheumatoid-arthritis-considering&catid=1016:reumatologia&Itemid=138 Annals of the Rheumatic Diseases current issue [email protected]Changes in classification criteria
Rheumatoid arthritis (RA) was recognised as a separate disease entity in the middle of the 20th century. Since then several sets of classification criteria were developed for use in clini ... ...
Changes in classification criteria
Rheumatoid arthritis (RA) was recognised as a separate disease entity in the middle of the 20th century. Since then several sets of classification criteria were developed for use in clini ... ...
EULAR revised recommendations for the management of fibromyalgia
2017-02-01T08:00:00Z 2017-02-01T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=215778:eular-revised-recommendations-management&catid=1016:reumatologia&Itemid=138 Annals of the Rheumatic Diseases current issue [email protected]Objective
The original European League Against Rheumatism recommendations for managing fibromyalgia assessed evidence up to 2005. The paucity of studies meant that most recommendations were ‘expert opinion’.
< ... ...
Objective
The original European League Against Rheumatism recommendations for managing fibromyalgia assessed evidence up to 2005. The paucity of studies meant that most recommendations were ‘expert opinion’.
< ... ...
Consensus-based recommendations for the management of juvenile dermatomyositis
2017-02-01T08:00:00Z 2017-02-01T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=215779:consensus-based-recommendations-management&catid=1016:reumatologia&Itemid=138 Annals of the Rheumatic Diseases current issue [email protected]Background
In 2012, a European initiative called Single Hub and Access point for pediatric Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic and management regimens ... ...
Background
In 2012, a European initiative called Single Hub and Access point for pediatric Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic and management regimens ... ...
Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EU
2017-02-01T08:00:00Z 2017-02-01T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=215780:patients-with-seronegative-have&catid=1016:reumatologia&Itemid=138 Annals of the Rheumatic Diseases current issue [email protected]Objectives
To compare the presentation of seropositive and seronegative early rheumatoid arthritis (RA) in disease-modifying antirheumatic drug (DMARD)-naïve patients classified according to the 2010 American College of Rheu ... ...
Objectives
To compare the presentation of seropositive and seronegative early rheumatoid arthritis (RA) in disease-modifying antirheumatic drug (DMARD)-naïve patients classified according to the 2010 American College of Rheu ... ...
Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study
2017-02-01T08:00:00Z 2017-02-01T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=215781:efficacy-safety-switching-from&catid=1016:reumatologia&Itemid=138 Annals of the Rheumatic Diseases current issue [email protected]Objectives
To investigate the efficacy and safety of switching from infliximab reference product (RP) to its biosimilar or maintaining biosimilar treatment in patients with ankylosing spondylitis (AS).
MethodsObjectives
To investigate the efficacy and safety of switching from infliximab reference product (RP) to its biosimilar or maintaining biosimilar treatment in patients with ankylosing spondylitis (AS).
MethodsEfficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA exte
2017-02-01T08:00:00Z 2017-02-01T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=215782:efficacy-safety-biosimilar-infliximab&catid=1016:reumatologia&Itemid=138 Annals of the Rheumatic Diseases current issue [email protected]Objectives
To assess the efficacy and safety of switching from the infliximab reference product (RP; Remicade) to its biosimilar CT-P13 (Remsima, Inflectra) or continuing CT-P13 in patients with rheumatoid arthritis (RA) for an addi ... ...
Objectives
To assess the efficacy and safety of switching from the infliximab reference product (RP; Remicade) to its biosimilar CT-P13 (Remsima, Inflectra) or continuing CT-P13 in patients with rheumatoid arthritis (RA) for an addi ... ...
Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis
2017-02-01T08:00:00Z 2017-02-01T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=215783:ankylosing-spondylitis-risk-factor&catid=1016:reumatologia&Itemid=138 Annals of the Rheumatic Diseases current issue [email protected]Aims
To assess and compare the incidence of cardiovascular (CV) events, by CV phenotype, between patients with ankylosing spondylitis (AS), rheumatoid arthritis (RA) and the general population.
Methods
Us ... ...
Aims
To assess and compare the incidence of cardiovascular (CV) events, by CV phenotype, between patients with ankylosing spondylitis (AS), rheumatoid arthritis (RA) and the general population.
Methods
Us ... ...
Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis
2017-02-01T08:00:00Z 2017-02-01T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=215784:disease-activity-associated-with&catid=1016:reumatologia&Itemid=138 Annals of the Rheumatic Diseases current issue [email protected]Objectives
Disease activity has emerged as a new, independent risk factor for cardiovascular disease in patients with rheumatoid arthritis (RA). We tested if disease activity in RA was associated with lower left ventricular (LV) sys ... ...
Objectives
Disease activity has emerged as a new, independent risk factor for cardiovascular disease in patients with rheumatoid arthritis (RA). We tested if disease activity in RA was associated with lower left ventricular (LV) sys ... ...
